ALVO Stock Latest News

ALVO Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

8d ago

Teva, Alvotech announces U.S. availability of SELARSDI injection

PremiumThe Fly

11d ago

Alvotech’s AVT06 Biosimilar Application Accepted by FDA

PremiumCompany Announcements

14d ago

Alvotech and Teva’s BLA filing for AVT06 accepted by FDA

PremiumThe Fly

14d ago

PremiumThe FlyAlvotech initiated with a Buy at UBS

18d ago

Company Announcements

FDA Accepts Alvotech’s Biosimilar Applications for Review

1M ago

The Fly

Alvotech, Teva announce FDA accepts BLA for AVT05

1M ago

Alvotech Joins Nasdaq Biotechnology Index, Boosting Industry Presence

PremiumCompany Announcements

2M ago

Alvotech Reports Strong Revenue Growth in 2024

PremiumCompany Announcements

4M ago

Alvotech Showcases Strong Financial Growth and Expansion

PremiumCompany Announcements

4M ago

ALVO Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

4M ago

PremiumCompany AnnouncementsAlvotech’s AVT05 Biosimilar Application Accepted by EMA

4M ago

The Fly

Alvotech announces EMA acceptance of MAA for AVT05

4M ago

Company Announcements

Alvotech and Teva Secure FDA Approval for SELARSDI

4M ago

Teva, Alvotech announce U.S. FDA approval of presentation of SELARSDI

PremiumThe Fly

4M ago

Alvotech Advances With EU Application Acceptance

PremiumCompany Announcements

5M ago

Alvotech files to sell 1.79M ordinary shares for holders

PremiumThe Fly

6M ago

Alvotech Reports Revenue Surge Amidst Expansion

PremiumCompany Announcements

7M ago

PremiumCompany AnnouncementsAlvotech’s Biosimilar AVT06 Eyes European Market

7M ago

The Fly

Alvotech price target lowered to $18 from $22 at Barclays

7M ago

Company Announcements

Alvotech Launches First Stelara Biosimilar in Europe

8M ago